Feed RHT.AX
RH
Resonance Health Limited
RHT.AX · ASX
$0.06 -5.00% (-$0.00)
1M +39.53%
Market Cap $28.6M
P/E Ratio -
Div. Yield -
ROE 16.78%
Bulios Fair Price
$0.03
47.4% downside
Preț actual
$0.057
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile RHT.AX sunt în prezent supraevaluate față de prețul lor de piață. Cum funcționează?
Valuation
47 /100
Fair P/B 3.05x
P/FCF 35.54x
P/S 2.59x
Growth
79 /100
Growing Book val. growth 4.23%
Rev. growth 42.48%
FCF growth N/A
Profitability
35 /100
Moderate Net margin 15.65%
Op. margin 17.42%
FCF margin 7.27%
Quality
8 /100
Poor ROE 16.78%
ROA 9.69%
Asset turnover 0.62x
Debt
55 /100
Moderate Current ratio 1.28x
Int. coverage -4.97x
Debt/Equity 0.40x
Stability
20 /100
Unstable Rev. volatility 42.74%
EPS volatility 652.72%
Profitable years 0
Întreabă StockBot despre RHT.AX
Online
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Andrew Duncan Harrison
Employees
18
Headquarters
Burswood